National Bank of Canada’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

National Bank of Canada’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-155	Closed	-$2.86K	–	2943
2023 Q3	$2.86K	Hold	155	–	–	﹤0.01%	2461
2023 Q2	$1.71K	Buy	155 +60	+63%	+$836	﹤0.01%	2492
2023 Q1	$1.27K	Hold	95	–	–	﹤0.01%	2498
2022 Q4	$1.18K	Buy	95 +40	+73%	+$566	﹤0.01%	2570
2022 Q3	$1K	Hold	55	–	–	﹤0.01%	2659
2022 Q2	$1K	Hold	55	–	–	﹤0.01%	2743
2022 Q1	$1K	Hold	55	–	–	﹤0.01%	2820
2021 Q4	$1K	Buy	+55	New	+$927	﹤0.01%	2784

National Bank of Canada's ICPT Position: Q4 2023 in Review

National Bank of Canada sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 155 shares — an estimated $2.86K sold.

National Bank of Canada first reported a position in ICPT in Q4 2021 and held it in 8 quarters. The position peaked at $2.86K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

National Bank of Canada reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
National Bank of Canada sold 155 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $2.86K.
National Bank of Canada first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2021 and held it in 8 quarters.
National Bank of Canada's Intercept Pharmaceuticals, Inc. position peaked at $2.86K in Q3 2023.
0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.